Medication info

Cozartan Plus Tablets

Prescription medicationTabletOralExpired
Ingredient · strength
Losartan Potassium›50mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Austin Pharmaceutical Co., Ltd.
Appearance
Yellow oval film-coated tablets
Packaging
30 tablets/bottle, 200 tablets/bottle
Approval status
Expired

MFDS item code 200608372 · Notified 2006.11.07

This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
○ Adults The usual dose of this medicine is 1 tablet once daily containing losartan potassium 50 mg/hydrochlorothiazide 12.5 mg. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg per day are not recommended. The maximum antihypertensive effect generally occurs approximately 3 weeks after the start of treatment. This medicine may be administered with other antihypertensive agents and may be taken without regard to meals. To minimize adverse reactions, start this medicine when the desired effect is not achieved with monotherapy. 1. Replacement therapy: Concomitant therapy with separately dose-adjusted losartan potassium and hydrochlorothiazide may be replaced with this medicine. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Start with 1 tablet once daily containing losartan potassium 50 mg/hydrochlorothiazide 12.5 mg. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet once daily containing losartan potassium 100 mg/hydrochlorothiazide 25 mg. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Start with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet once daily containing losartan potassium 100 mg/hydrochlorothiazide 25 mg. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who have hypokalemia even when blood pressure is controlled at this dose: Treatment may be started with 1 tablet once daily containing losartan potassium 50 mg/hydrochlorothiazide 12.5 mg, which can reduce the hydrochlorothiazide dose without reducing the overall antihypertensive effect. Thereafter, continue to assess the clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg; if blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet once daily containing losartan potassium 100 mg/hydrochlorothiazide 25 mg. ○ Patients with renal impairment Use the usual dose in patients with creatinine clearance of 30 mL/min or higher. Use of loop diuretics rather than thiazide drugs is preferable in patients with more severe renal impairment; therefore, use in these patients is not recommended. ○ Patients with hepatic impairment Use in patients with hepatic impairment requiring dose adjustment is not recommended because the initial dose of losartan potassium for these patients, 25 mg, cannot be administered with this medicine.
Child dose
Under 18 years: There is no experience with use in children and adolescents; therefore, the losartan-hydrochlorothiazide combination should not be administered to children and adolescents.

Ingredients

Manufacturer
Austin Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension not controlled with monotherapy

  • Hypertension
View approved original text

This medication is used in patients with hypertension whose blood pressure is not adequately controlled with monotherapy. It helps manage blood pressure more effectively through combination therapy. Hypertension can increase the risk of cardiovascular diseases, so adequate treatment is very important. This drug contributes to stable lowering of blood pressure, reducing the burden on the heart and maintaining a healthy vascular condition. Therefore, it is used as a treatment that aids in blood pressure control.

How to take

Adult dose

○ Adults The usual dose of this medicine is 1 tablet once daily containing losartan potassium 50 mg/hydrochlorothiazide 12.5 mg. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg per day are not recommended. The maximum antihypertensive effect generally occurs approximately 3 weeks after the start of treatment. This medicine may be administered with other antihypertensive agents and may be taken without regard to meals. To minimize adverse reactions, start this medicine when the desired effect is not achieved with monotherapy. 1. Replacement therapy: Concomitant therapy with separately dose-adjusted losartan potassium and hydrochlorothiazide may be replaced with this medicine. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Start with 1 tablet once daily containing losartan potassium 50 mg/hydrochlorothiazide 12.5 mg. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet once daily containing losartan potassium 100 mg/hydrochlorothiazide 25 mg. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Start with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet once daily containing losartan potassium 100 mg/hydrochlorothiazide 25 mg. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who have hypokalemia even when blood pressure is controlled at this dose: Treatment may be started with 1 tablet once daily containing losartan potassium 50 mg/hydrochlorothiazide 12.5 mg, which can reduce the hydrochlorothiazide dose without reducing the overall antihypertensive effect. Thereafter, continue to assess the clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg; if blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet once daily containing losartan potassium 100 mg/hydrochlorothiazide 25 mg. ○ Patients with renal impairment Use the usual dose in patients with creatinine clearance of 30 mL/min or higher. Use of loop diuretics rather than thiazide drugs is preferable in patients with more severe renal impairment; therefore, use in these patients is not recommended. ○ Patients with hepatic impairment Use in patients with hepatic impairment requiring dose adjustment is not recommended because the initial dose of losartan potassium for these patients, 25 mg, cannot be administered with this medicine.

Child dose

Under 18 years: There is no experience with use in children and adolescents; therefore, the losartan-hydrochlorothiazide combination should not be administered to children and adolescents.

Precautions

This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. This drug should not be prescribed to patients with certain conditions or those who are allergic to the medication, particularly patients with severely impaired kidney function or significant liver dysfunction. During the use of this medication, blood pressure may drop too low, so it is essential to consult a physician immediately if symptoms of hypotension or dizziness occur. As electrolyte imbalances may occur, it is important to regularly check sodium, potassium, and other levels through blood tests. This drug can interact with other medications, so special caution should be taken to avoid using it alongside potassium supplements or medications containing potassium. Due to the hydrochlorothiazide component, skin sensitivity to sunlight may increase; therefore, it is advised to avoid prolonged sun exposure and to pay attention to UV protection. Adverse effects may occur more frequently in older adults, so they should take this medication with extra caution. If symptoms such as cough, rash, or swelling occur during use, it is critical to inform healthcare professionals and seek advice immediately. Care is needed when driving or operating machinery as dizziness or drowsiness may occur. This medication has limited use experience in children and adolescents; therefore, it is best not to administer it to them.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • abdominal pain
  • edema
  • palpitations
  • low back pain
  • dizziness
Show 128 more
  • cough
  • sinusitis
  • upper respiratory infection
  • rash
  • angioedema
  • skin detachment phenomenon
  • hemolysis phenomenon
  • chest pain
  • facial edema
  • fever
  • orthostatic hypotension
  • syncope
  • angina
  • arrhythmia
  • cerebrovascular accident
  • myocardial infarction
  • secondary atrioventricular block
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • dyspepsia
  • flatulence
  • gastritis
  • vomiting
  • malaise
  • anemia
  • gout
  • arm pain
  • joint pain
  • arthritis
  • fibromyalgia
  • hip pain
  • joint swelling
  • knee pain
  • limb pain
  • muscle cramps
  • muscle weakness
  • musculoskeletal pain
  • myalgia
  • shoulder pain
  • muscle rigidity
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory loss
  • insomnia
  • reduced libido
  • memory impairment
  • migraine
  • hyperesthesia
  • panic disorder
  • paresthesia
  • peripheral neuropathy
  • sleep disorders
  • drowsiness
  • tremor
  • dyspnea
  • epistaxis
  • nasal congestion
  • pharyngeal discomfort
  • respiratory congestion
  • rhinitis
  • venous obstruction
  • chest discomfort
  • alopecia
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photoallergic reactions
  • pruritus
  • sweating
  • urticaria
  • blurred vision
  • ocular pain
  • burning sensation
  • conjunctivitis
  • decreased vision
  • taste disturbance
  • tinnitus
  • erectile dysfunction
  • nocturia
  • polyuria
  • urinary tract infection
  • weakness
  • pancreatitis
  • jaundice
  • sialadenitis
  • convulsions
  • gastrointestinal irritation
  • aplastic anemia
  • agranulocytosis
  • leukopenia
  • thrombocytopenia
  • purpura
  • necrotizing vasculitis
  • pneumonia
  • pulmonary edema
  • acute respiratory distress syndrome
  • hyperglycemia
  • diabetes
  • muscle spasms
  • agitation
  • renal failure
  • renal dysfunction
  • interstitial nephritis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • transient blurred vision
  • xanthopsia
  • acute myopia
  • acute closed-angle glaucoma
  • hypotension
  • tachycardia
  • angioedema
  • vasculitis
  • anaphylaxis
  • hepatitis
  • dry cough
  • erythema
  • hyperkalemia
  • hyponatremia
  • rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a container that blocks light and air, and it is safe to keep it at room temperature between 1°C to 30°C. Storing it this way will help maintain the drug’s efficacy for an extended period.

Appearance and packaging

Appearance

Yellow oval film-coated tablets

Package unit

30 tablets/bottle, 200 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.